High Doses of Dexamethasone Improved Hemoglobin Levels Lowered by Corona Virus in COVID-19 Infected Patients: Dexamethasone and Hemoglobin in COVID-19

Zunnera Rashid  Chaudhry; Sabeen Shakir; Sana Rasheed; Erum Rashid; Hifza Noor Lodhi; Naima Shakeel

doi:10.54393/pjhs.v5i05.1585

Authors

Zunnera Rashid Chaudhry Department of Pharmacology, Akhtar Saeed Medical College, Rawalpindi, Pakistan
Sabeen Shakir Department of Pharmacology, Akhtar Saeed Medical College, Rawalpindi, Pakistan
Sana Rasheed Department of Physiology, Ameer-Ud-Din Medical College, Lahore, Pakistan
Erum Rashid Department of Biochemistry, Watim Medical College, Rawalpindi, Pakistan
Hifza Noor Lodhi Department of Physiology, Rashid Latif Khan University, Lahore, Pakistan
Naima Shakeel Department of Physiology, Postgraduate Medical Institute, Ameer-Ud-Din Medical College, Lahore General Hospital, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i05.1585

Keywords:

Corona Virus, Dexamethasone, Hemoglobin Level, Steroid Therapy

Abstract

Corona virus an infectious disease caused by SARS–CoV-2 virus that lower hemoglobin level leading to worsening of the conditions. The respiratory symptoms are treated by steroids and patients are rapidly recovered. Objective: To study the effect of high and low doses of dexamethasone on hemoglobin level in COVID-19 infected patients. Methods: This experimental study was carried out in Rawal Institute of Health Sciences, Islamabad and Pakistan Institute of Medical Sciences, Islamabad between May 2021 to Sep 2021 on 100 adult male and female of COVID-19 patients having blood hemoglobin level < 10 g/dl. For different doses of dexamethasone patients were divided into two groups of 50 patients in each group. Blood samples were taken on day 01 and day 15 for hemoglobin analysis. Mean and standard deviation of both groups was calculated and p-value of < 0.05 was considered significant. Results: At the time of admission 74% of the patients had a cough, 89% of the patients presented with fever, 98% had increased heart rate whereas 100% of the patients presented with the complaint of fatigue. Mean Hemoglobin (Hb) levels of both groups were compared on day 01 and day 15 respectively. The comparison of Hb levels showed a significant difference on day 15, there was a marked increase in Hb levels in the group which was taking 12mg/day of dexamethasone as compared to the group which was taking 6mg/day of dexamethasone (P-value <0.05). Conclusions: Administration of high doses of Dexamethasone caused a pronounced increase in hemoglobin levels in COVID-19 patients

References

Keam S, Megawati D, Patel SK, Tiwari R, Dhama K, Harapan H. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. Reviews in Medical Virology. 2020 Sep; 30(5): e2123. doi: 10.1002/rmv.2123. DOI: https://doi.org/10.1002/rmv.2123

Li H, Wang Y, Ji M, Pei F, Zhao Q, Zhou Y et al. Transmission routes analysis of SARS-CoV-2: a systematic review and case report. Frontiers in Cell and Developmental Biology. 2020 Jul; 8: 618. doi: 10.3389/fcell.2020.00618. DOI: https://doi.org/10.3389/fcell.2020.00618

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 2020 Dec; 7: 1-23. doi: 10.1186/s40779-020-0233-6. DOI: https://doi.org/10.1186/s40779-020-0233-6

Rahman HS, Aziz MS, Hussein RH, Othman HH, Omer SH, Khalid ES et al. The transmission modes and sources of COVID-19: A systematic review. International Journal of Surgery Open. 2020 Jan; 26: 125-36. doi: 10.1016/j.ijso.2020.08.017. DOI: https://doi.org/10.1016/j.ijso.2020.08.017

Hopp MT, Domingo-Fernández D, Gadiya Y, Detzel MS, Schmalohr BF, Steinbock F et al. Unravelling the debate on heme effects in COVID-19 infections. bioRxiv 2020 Jun; 10: 2020-06. doi: 10.1101/2020.06.09.142125. DOI: https://doi.org/10.1101/2020.06.09.142125

Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clinics and Practice. 2020 May; 10(2): 1271. doi: 10.4081/cp.2020.1271. DOI: https://doi.org/10.4081/cp.2020.1271

Mehta J, Rolta R, Mehta BB, Kaushik N, Choi EH, Kaushik NK. Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review. Frontiers in Microbiology. 2022 Feb; 13:813358. doi: 10.3389/fmicb.2022.813358. DOI: https://doi.org/10.3389/fmicb.2022.813358

Seo SJ and Priefer R. Dexamethasone Mechanism in Inflammatory Immune Mediated Disease and its Application in Treating 2019 Coronavirus Disease (COVID-19). Medical Research Archives. 2020 Dec; 8(12): 2020. doi: 10.18103/mra.v8i12.2267. DOI: https://doi.org/10.18103/mra.v8i12.2267

Zhang G, Su L, Wu W, Qiao Q, Gao S, Zhang Y et al. Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia. Virology Journal. 2024 Mar; 21(1): 74. doi: 10.1186/s12985-024-02345-7. DOI: https://doi.org/10.1186/s12985-024-02345-7

Salari N, Khodayari Y, Hosseinian-Far A, Zarei H, Rasoulpoor S, Akbari H, Mohammadi M. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. BioPsychoSocial Medicine. 2022 Oct; 16(1): 21. doi: 10.1186/s13030-022-00250-5. DOI: https://doi.org/10.1186/s13030-022-00250-5

Saeed U, Uppal SR, Piracha ZZ, Khan AA, Rasheed A, Zaheer H, Aftab Z, Uppal R. Effectivity analysis of SARS-CoV-2 nasopharyngeal swab rapid testing kits in Pakistan: A scenario of inadequate COVID-19 diagnosis. Research Square. 2021 Mar. [Preprint]. DOI: https://doi.org/10.21203/rs.3.rs-315851/v1

Shiravi AA, Saadat M, Abdollahi Z, Miar P, Khanahmad H, Zeinalian M. Vitamin D can be effective against COVID-19 and other similar viral infections: a review on molecular aspects. Zenodo. 2020 Mar; 92(2): 134-146. doi: 10.1024/0300-9831/a000676. DOI: https://doi.org/10.1024/0300-9831/a000676

Paul P, Maiti D, Adhikary T. Iron deficiency anemia-An updated overview. International Journal of Research in Pharmacy and Pharmaceutical Sciences. 2021 Sep; 6(4): 28-33.

Miwa T, Hatano Y, Kochi T, Aiba M, Toda K, Goto H, et al. Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review. Clinical Journal of Gastroenterology. 2020 Oct; 13: 882-90. doi: 10.1007/s12328-020-01142-3. DOI: https://doi.org/10.1007/s12328-020-01142-3

Russell L, Uhre KR, Lindgaard AL, Degn JF, Wetterslev M, Sivapalan P et al. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID steroid 2 randomized trial. The Journal of the American Medical Association. 2021 Nov; 326(18): 1807-17.

Anai M, Akaike K, Iwagoe H, Akasaka T, Higuchi T, Miyazaki A et al. Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respiratory Investigation. 2021 Mar; 59(2): 187-93. doi: 10.1016/j.resinv.2020.10.009. DOI: https://doi.org/10.1016/j.resinv.2020.10.009

Nóbrega F, Mauad VA, Borducchi DM. Does COVID‐19 really impact on the oxy‐hemoglobin dissociation curve? eJHaem. 2020 Nov; 1(2): 604-7. doi: 10.1002/jha2.126. DOI: https://doi.org/10.1002/jha2.126

Russo A, Tellone E, Barreca D, Ficarra S, Lagana G. Implication of COVID-19 on erythrocytes functionality: red blood cell biochemical implications and morpho-functional aspects. International Journal of Molecular Sciences. 2022 Feb; 23(4): 2171. doi: 10.3390/ijms23042171. DOI: https://doi.org/10.3390/ijms23042171

Bahsoun A, Fakih Y, Zareef R, Bitar F, Arabi M. Corticosteroids in COVID-19: pros and cons. Frontiers in Medicine. 2023 Aug; 10: 1202504. doi: 10.3389/fmed.2023.1202504. DOI: https://doi.org/10.3389/fmed.2023.1202504

Karam D, Swiatkowski S, Purohit P, Agrawal B. High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia. Case Reports. 2018 Jan; 2018: bcr-2017. doi: 10.1136/bcr-2017-223281. DOI: https://doi.org/10.1136/bcr-2017-223281

Ashley R, Yan H, Wang N, Hale J, Dulmovits BM, Papoin J, Olive M, Udeshi N, Carr S, Vlachos A, Lipton JM. Glucocorticoids Induce the Maintenance and Expansion of an Immature CFU-E Erythroid Progenitor Population in Humans. Blood. 2019 Nov; 134: 943. doi: 10.1182/blood-2019-130710. DOI: https://doi.org/10.1182/blood-2019-130710

Al-Ansari RY, Alromaih L, Osman M. Steroid induced hypertriglyceridemia in pregnant women with immune thrombocytopenia-case report. Annals of Medicine and Surgery. 2022 May; 77: 103636. doi: 10.1016/j.amsu.2022.103636. DOI: https://doi.org/10.1016/j.amsu.2022.103636

NB, Bonne TC, Sørensen H, Bejder J. Glucocorticoids accelerate erythropoiesis in healthy humans-should the use in sports be reevaluated?. Medicine and Science in Sports and Exercise. 2023 Feb; 55(7): 1334-1341. doi: 10.1249/MSS.0000000000003156. DOI: https://doi.org/10.1249/MSS.0000000000003156

Hsu RJ, Yu WC, Peng GR, Ye CH, Hu S, Chong PC et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Frontiers in Immunology. 2022 Apr; 13: 832394. doi: 10.3389/fimmu.2022.832394. DOI: https://doi.org/10.3389/fimmu.2022.832394